New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration-- and researchers now think they ...

Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from age-related macular degeneration, a progressive disease afflicting about 11 ...

Dr. Ali points out that historically, there haven’t been any advanced dry macular degeneration treatment options approved by the FDA. However, that changed in 2023. “The two FDA approved ...

A study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window GA lesions, which form on the retina due to degeneration of pigment epithelium and photoreceptors, significantly impact ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

The Healthcare Private Equity team has advised Retina Consultants of America (RCA) and Webster Equity Partners in the sale of ...

Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA ...

Sandoz (SDZNY) said that the European Commission has granted marketing authorization for Afqlir (aflibercept) 2 mg vial kit and ...